Phaos Technology Holdings (Cayman) (POAS) Total Liabilities (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Total Liabilities of $4.8 million for Q4 2025, up 62.95% on a QoQ basis from $2.9 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Total Liabilities (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Total Liabilities history runs 2 years deep, the most recent figure standing at $4.8 million for Q4 2025.
- Quarterly Total Liabilities changed N/A year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $4.8 million (changed N/A YoY) and the FY2025 annual result came in at $2.9 million, up 73.56% from the prior year.
- Total Liabilities was $4.8 million for Q4 2025 at Phaos Technology Holdings (Cayman), up from $2.9 million in the prior quarter.
- Across five years, Total Liabilities topped out at $4.8 million in Q4 2025 and bottomed at $1.7 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | 26.23 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | 5.17 Bn |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 18.55 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.17 Mn | 6.12 Mn | - | 4.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 4.75 Mn |
| Apr 30, 2025 | 2.92 Mn |
| Apr 30, 2024 | 1.68 Mn |